nodes	percent_of_prediction	percent_of_DWPC	metapath
Mecamylamine—CHRNB4—Galantamine—Alzheimer's disease	0.336	0.428	CbGbCtD
Mecamylamine—CHRNA3—Galantamine—Alzheimer's disease	0.281	0.358	CbGbCtD
Mecamylamine—CHRNA2—Galantamine—Alzheimer's disease	0.168	0.214	CbGbCtD
Mecamylamine—CHRNB4—Highly sodium permeable acetylcholine nicotinic receptors—CHRNB2—Alzheimer's disease	0.00371	0.0299	CbGpPWpGaD
Mecamylamine—CHRNB4—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA7—Alzheimer's disease	0.0036	0.029	CbGpPWpGaD
Mecamylamine—CHRNA3—Highly sodium permeable acetylcholine nicotinic receptors—CHRNB2—Alzheimer's disease	0.0034	0.0273	CbGpPWpGaD
Mecamylamine—CHRNB4—Highly sodium permeable acetylcholine nicotinic receptors—CHRNA4—Alzheimer's disease	0.00337	0.0271	CbGpPWpGaD
Mecamylamine—CHRNA3—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA7—Alzheimer's disease	0.0033	0.0265	CbGpPWpGaD
Mecamylamine—CHRNA3—Highly sodium permeable acetylcholine nicotinic receptors—CHRNA4—Alzheimer's disease	0.00308	0.0248	CbGpPWpGaD
Mecamylamine—CHRNB4—Highly calcium permeable nicotinic acetylcholine receptors—CHRNB2—Alzheimer's disease	0.00304	0.0244	CbGpPWpGaD
Mecamylamine—CHRNB4—Acetylcholine Binding And Downstream Events—CHRNA7—Alzheimer's disease	0.00297	0.0239	CbGpPWpGaD
Mecamylamine—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA7—Alzheimer's disease	0.00294	0.0237	CbGpPWpGaD
Mecamylamine—CHRNA3—Highly calcium permeable nicotinic acetylcholine receptors—CHRNB2—Alzheimer's disease	0.00278	0.0223	CbGpPWpGaD
Mecamylamine—CHRNB4—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA4—Alzheimer's disease	0.00276	0.0222	CbGpPWpGaD
Mecamylamine—CHRNA3—Acetylcholine Binding And Downstream Events—CHRNA7—Alzheimer's disease	0.00272	0.0219	CbGpPWpGaD
Mecamylamine—Ileus—Donepezil—Alzheimer's disease	0.00271	0.0385	CcSEcCtD
Mecamylamine—CHRNB4—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNB2—Alzheimer's disease	0.00259	0.0208	CbGpPWpGaD
Mecamylamine—CHRNA3—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA4—Alzheimer's disease	0.00252	0.0203	CbGpPWpGaD
Mecamylamine—CHRNA2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNB2—Alzheimer's disease	0.00248	0.0199	CbGpPWpGaD
Mecamylamine—Ileus—Memantine—Alzheimer's disease	0.00246	0.0349	CcSEcCtD
Mecamylamine—CHRNA3—forebrain—Alzheimer's disease	0.00245	0.122	CbGeAlD
Mecamylamine—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNA7—Alzheimer's disease	0.00242	0.0195	CbGpPWpGaD
Mecamylamine—CHRNB4—Presynaptic nicotinic acetylcholine receptors—CHRNB2—Alzheimer's disease	0.00241	0.0194	CbGpPWpGaD
Mecamylamine—CHRNA3—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNB2—Alzheimer's disease	0.00237	0.019	CbGpPWpGaD
Mecamylamine—CHRNB4—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA4—Alzheimer's disease	0.00235	0.0189	CbGpPWpGaD
Mecamylamine—CHRNA2—forebrain—Alzheimer's disease	0.00228	0.114	CbGeAlD
Mecamylamine—CHRNA2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA4—Alzheimer's disease	0.00225	0.0181	CbGpPWpGaD
Mecamylamine—CHRNA3—Presynaptic nicotinic acetylcholine receptors—CHRNB2—Alzheimer's disease	0.00221	0.0178	CbGpPWpGaD
Mecamylamine—CHRNB4—Presynaptic nicotinic acetylcholine receptors—CHRNA4—Alzheimer's disease	0.00219	0.0176	CbGpPWpGaD
Mecamylamine—CHRNB4—nervous system—Alzheimer's disease	0.00217	0.108	CbGeAlD
Mecamylamine—CHRNA3—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA4—Alzheimer's disease	0.00215	0.0173	CbGpPWpGaD
Mecamylamine—CHRNB4—Acetylcholine Binding And Downstream Events—CHRNB2—Alzheimer's disease	0.00213	0.0172	CbGpPWpGaD
Mecamylamine—CHRNA3—Nicotine Activity on Dopaminergic Neurons—CDK5—Alzheimer's disease	0.00211	0.017	CbGpPWpGaD
Mecamylamine—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNB2—Alzheimer's disease	0.00211	0.017	CbGpPWpGaD
Mecamylamine—CHRNB4—central nervous system—Alzheimer's disease	0.00209	0.104	CbGeAlD
Mecamylamine—CHRNA3—Presynaptic nicotinic acetylcholine receptors—CHRNA4—Alzheimer's disease	0.002	0.0161	CbGpPWpGaD
Mecamylamine—CHRNA2—Presynaptic nicotinic acetylcholine receptors—CHRNB2—Alzheimer's disease	0.00197	0.0158	CbGpPWpGaD
Mecamylamine—CHRNA3—Acetylcholine Binding And Downstream Events—CHRNB2—Alzheimer's disease	0.00195	0.0157	CbGpPWpGaD
Mecamylamine—CHRNB4—Acetylcholine Binding And Downstream Events—CHRNA4—Alzheimer's disease	0.00194	0.0156	CbGpPWpGaD
Mecamylamine—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA4—Alzheimer's disease	0.00192	0.0154	CbGpPWpGaD
Mecamylamine—Glossitis—Rivastigmine—Alzheimer's disease	0.00185	0.0262	CcSEcCtD
Mecamylamine—CHRNA2—Presynaptic nicotinic acetylcholine receptors—CHRNA4—Alzheimer's disease	0.00179	0.0144	CbGpPWpGaD
Mecamylamine—Disturbance in sexual arousal—Galantamine—Alzheimer's disease	0.00178	0.0253	CcSEcCtD
Mecamylamine—CHRNA3—Acetylcholine Binding And Downstream Events—CHRNA4—Alzheimer's disease	0.00177	0.0142	CbGpPWpGaD
Mecamylamine—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNB2—Alzheimer's disease	0.00174	0.014	CbGpPWpGaD
Mecamylamine—Urinary retention—Galantamine—Alzheimer's disease	0.00171	0.0242	CcSEcCtD
Mecamylamine—CHRNB4—brain—Alzheimer's disease	0.00166	0.0826	CbGeAlD
Mecamylamine—Orthostatic hypotension—Galantamine—Alzheimer's disease	0.00164	0.0233	CcSEcCtD
Mecamylamine—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNA4—Alzheimer's disease	0.00158	0.0127	CbGpPWpGaD
Mecamylamine—Pulmonary oedema—Memantine—Alzheimer's disease	0.00155	0.022	CcSEcCtD
Mecamylamine—Pulmonary oedema—Rivastigmine—Alzheimer's disease	0.00152	0.0215	CcSEcCtD
Mecamylamine—Libido decreased—Donepezil—Alzheimer's disease	0.0015	0.0213	CcSEcCtD
Mecamylamine—CHRNA3—Nicotine Activity on Dopaminergic Neurons—CHRNB2—Alzheimer's disease	0.00141	0.0113	CbGpPWpGaD
Mecamylamine—Disturbance in sexual arousal—Donepezil—Alzheimer's disease	0.00138	0.0196	CcSEcCtD
Mecamylamine—Libido decreased—Memantine—Alzheimer's disease	0.00136	0.0193	CcSEcCtD
Mecamylamine—Libido decreased—Rivastigmine—Alzheimer's disease	0.00133	0.0189	CcSEcCtD
Mecamylamine—CHRNA3—nervous system—Alzheimer's disease	0.00133	0.0663	CbGeAlD
Mecamylamine—Urinary retention—Donepezil—Alzheimer's disease	0.00132	0.0188	CcSEcCtD
Mecamylamine—CHRNA3—central nervous system—Alzheimer's disease	0.00128	0.0638	CbGeAlD
Mecamylamine—CHRNA3—Nicotine Activity on Dopaminergic Neurons—CHRNA4—Alzheimer's disease	0.00128	0.0103	CbGpPWpGaD
Mecamylamine—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.00127	0.018	CcSEcCtD
Mecamylamine—Disturbance in sexual arousal—Memantine—Alzheimer's disease	0.00125	0.0178	CcSEcCtD
Mecamylamine—CHRNA3—cerebellum—Alzheimer's disease	0.00125	0.0624	CbGeAlD
Mecamylamine—CHRNA2—nervous system—Alzheimer's disease	0.00124	0.0617	CbGeAlD
Mecamylamine—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.00123	0.0174	CcSEcCtD
Mecamylamine—Urinary retention—Memantine—Alzheimer's disease	0.0012	0.0171	CcSEcCtD
Mecamylamine—CHRNA2—central nervous system—Alzheimer's disease	0.00119	0.0594	CbGeAlD
Mecamylamine—Urinary retention—Rivastigmine—Alzheimer's disease	0.00118	0.0167	CcSEcCtD
Mecamylamine—CHRNA2—cerebellum—Alzheimer's disease	0.00117	0.058	CbGeAlD
Mecamylamine—Orthostatic hypotension—Memantine—Alzheimer's disease	0.00115	0.0164	CcSEcCtD
Mecamylamine—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.00113	0.016	CcSEcCtD
Mecamylamine—Vision blurred—Galantamine—Alzheimer's disease	0.00102	0.0145	CcSEcCtD
Mecamylamine—CHRNA3—brain—Alzheimer's disease	0.00102	0.0507	CbGeAlD
Mecamylamine—Tremor—Galantamine—Alzheimer's disease	0.00101	0.0144	CcSEcCtD
Mecamylamine—Erectile dysfunction—Memantine—Alzheimer's disease	0.00101	0.0143	CcSEcCtD
Mecamylamine—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000985	0.014	CcSEcCtD
Mecamylamine—Syncope—Galantamine—Alzheimer's disease	0.000971	0.0138	CcSEcCtD
Mecamylamine—Loss of consciousness—Galantamine—Alzheimer's disease	0.000951	0.0135	CcSEcCtD
Mecamylamine—CHRNA2—brain—Alzheimer's disease	0.000946	0.0471	CbGeAlD
Mecamylamine—Convulsion—Galantamine—Alzheimer's disease	0.000938	0.0133	CcSEcCtD
Mecamylamine—Shock—Galantamine—Alzheimer's disease	0.000869	0.0123	CcSEcCtD
Mecamylamine—Anorexia—Galantamine—Alzheimer's disease	0.000842	0.0119	CcSEcCtD
Mecamylamine—Paraesthesia—Galantamine—Alzheimer's disease	0.000793	0.0113	CcSEcCtD
Mecamylamine—Vision blurred—Donepezil—Alzheimer's disease	0.00079	0.0112	CcSEcCtD
Mecamylamine—Tremor—Donepezil—Alzheimer's disease	0.000786	0.0111	CcSEcCtD
Mecamylamine—Decreased appetite—Galantamine—Alzheimer's disease	0.000768	0.0109	CcSEcCtD
Mecamylamine—Fatigue—Galantamine—Alzheimer's disease	0.000762	0.0108	CcSEcCtD
Mecamylamine—Constipation—Galantamine—Alzheimer's disease	0.000755	0.0107	CcSEcCtD
Mecamylamine—Syncope—Donepezil—Alzheimer's disease	0.000752	0.0107	CcSEcCtD
Mecamylamine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000737	0.0105	CcSEcCtD
Mecamylamine—Convulsion—Donepezil—Alzheimer's disease	0.000727	0.0103	CcSEcCtD
Mecamylamine—Vision blurred—Memantine—Alzheimer's disease	0.000718	0.0102	CcSEcCtD
Mecamylamine—Tremor—Memantine—Alzheimer's disease	0.000714	0.0101	CcSEcCtD
Mecamylamine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000702	0.00996	CcSEcCtD
Mecamylamine—Tremor—Rivastigmine—Alzheimer's disease	0.000698	0.0099	CcSEcCtD
Mecamylamine—Syncope—Memantine—Alzheimer's disease	0.000683	0.00969	CcSEcCtD
Mecamylamine—Shock—Donepezil—Alzheimer's disease	0.000673	0.00955	CcSEcCtD
Mecamylamine—Loss of consciousness—Memantine—Alzheimer's disease	0.000669	0.0095	CcSEcCtD
Mecamylamine—Syncope—Rivastigmine—Alzheimer's disease	0.000668	0.00948	CcSEcCtD
Mecamylamine—Convulsion—Memantine—Alzheimer's disease	0.00066	0.00936	CcSEcCtD
Mecamylamine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000655	0.00929	CcSEcCtD
Mecamylamine—Anorexia—Donepezil—Alzheimer's disease	0.000653	0.00926	CcSEcCtD
Mecamylamine—Convulsion—Rivastigmine—Alzheimer's disease	0.000646	0.00916	CcSEcCtD
Mecamylamine—Asthenia—Galantamine—Alzheimer's disease	0.000634	0.00899	CcSEcCtD
Mecamylamine—Paraesthesia—Donepezil—Alzheimer's disease	0.000615	0.00872	CcSEcCtD
Mecamylamine—Shock—Memantine—Alzheimer's disease	0.000611	0.00867	CcSEcCtD
Mecamylamine—Shock—Rivastigmine—Alzheimer's disease	0.000598	0.00849	CcSEcCtD
Mecamylamine—Decreased appetite—Donepezil—Alzheimer's disease	0.000595	0.00844	CcSEcCtD
Mecamylamine—Anorexia—Memantine—Alzheimer's disease	0.000592	0.0084	CcSEcCtD
Mecamylamine—Fatigue—Donepezil—Alzheimer's disease	0.00059	0.00837	CcSEcCtD
Mecamylamine—Constipation—Donepezil—Alzheimer's disease	0.000585	0.0083	CcSEcCtD
Mecamylamine—Dizziness—Galantamine—Alzheimer's disease	0.000584	0.00829	CcSEcCtD
Mecamylamine—Anorexia—Rivastigmine—Alzheimer's disease	0.00058	0.00822	CcSEcCtD
Mecamylamine—Vomiting—Galantamine—Alzheimer's disease	0.000562	0.00797	CcSEcCtD
Mecamylamine—Paraesthesia—Memantine—Alzheimer's disease	0.000558	0.00792	CcSEcCtD
Mecamylamine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000546	0.00775	CcSEcCtD
Mecamylamine—Decreased appetite—Memantine—Alzheimer's disease	0.00054	0.00766	CcSEcCtD
Mecamylamine—Fatigue—Memantine—Alzheimer's disease	0.000536	0.0076	CcSEcCtD
Mecamylamine—Constipation—Memantine—Alzheimer's disease	0.000532	0.00754	CcSEcCtD
Mecamylamine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000529	0.0075	CcSEcCtD
Mecamylamine—Nausea—Galantamine—Alzheimer's disease	0.000525	0.00744	CcSEcCtD
Mecamylamine—Fatigue—Rivastigmine—Alzheimer's disease	0.000524	0.00744	CcSEcCtD
Mecamylamine—Constipation—Rivastigmine—Alzheimer's disease	0.00052	0.00738	CcSEcCtD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.000508	0.00409	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—SLC18A3—Alzheimer's disease	0.000503	0.00404	CbGpPWpGaD
Mecamylamine—Asthenia—Donepezil—Alzheimer's disease	0.000491	0.00697	CcSEcCtD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Alzheimer's disease	0.000471	0.00379	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA7—Alzheimer's disease	0.000471	0.00379	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—SLC18A3—Alzheimer's disease	0.00046	0.0037	CbGpPWpGaD
Mecamylamine—Dizziness—Donepezil—Alzheimer's disease	0.000453	0.00642	CcSEcCtD
Mecamylamine—Asthenia—Memantine—Alzheimer's disease	0.000446	0.00633	CcSEcCtD
Mecamylamine—Asthenia—Rivastigmine—Alzheimer's disease	0.000436	0.00619	CcSEcCtD
Mecamylamine—Vomiting—Donepezil—Alzheimer's disease	0.000435	0.00617	CcSEcCtD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.000432	0.00347	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.000432	0.00347	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA7—Alzheimer's disease	0.000431	0.00347	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Alzheimer's disease	0.000431	0.00347	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.000418	0.00337	CbGpPWpGaD
Mecamylamine—Dizziness—Memantine—Alzheimer's disease	0.000411	0.00583	CcSEcCtD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—SLC18A3—Alzheimer's disease	0.00041	0.0033	CbGpPWpGaD
Mecamylamine—Nausea—Donepezil—Alzheimer's disease	0.000407	0.00577	CcSEcCtD
Mecamylamine—Dizziness—Rivastigmine—Alzheimer's disease	0.000402	0.0057	CcSEcCtD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Alzheimer's disease	0.0004	0.00322	CbGpPWpGaD
Mecamylamine—Vomiting—Memantine—Alzheimer's disease	0.000395	0.00561	CcSEcCtD
Mecamylamine—Vomiting—Rivastigmine—Alzheimer's disease	0.000387	0.00548	CcSEcCtD
Mecamylamine—CHRNB4—Neuronal System—SLC18A3—Alzheimer's disease	0.000385	0.0031	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA7—Alzheimer's disease	0.000384	0.00309	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Alzheimer's disease	0.000384	0.00309	CbGpPWpGaD
Mecamylamine—Nausea—Memantine—Alzheimer's disease	0.000369	0.00524	CcSEcCtD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.000367	0.00295	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Alzheimer's disease	0.000366	0.00295	CbGpPWpGaD
Mecamylamine—Nausea—Rivastigmine—Alzheimer's disease	0.000361	0.00512	CcSEcCtD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA1—Alzheimer's disease	0.000357	0.00287	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—GRIK1—Alzheimer's disease	0.000354	0.00285	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—CHRNA7—Alzheimer's disease	0.000354	0.00285	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—SLC18A3—Alzheimer's disease	0.000352	0.00283	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.000345	0.00278	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.000339	0.00273	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—Alzheimer's disease	0.000338	0.00272	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Alzheimer's disease	0.000327	0.00263	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA1—Alzheimer's disease	0.000326	0.00263	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—GRIK1—Alzheimer's disease	0.000324	0.00261	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—CHRNA7—Alzheimer's disease	0.000324	0.00261	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—SLC18A3—Alzheimer's disease	0.000314	0.00253	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.00031	0.00249	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—Alzheimer's disease	0.000309	0.00249	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Alzheimer's disease	0.000307	0.00247	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—GRIK2—Alzheimer's disease	0.000301	0.00242	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—CHAT—Alzheimer's disease	0.000301	0.00242	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA1—Alzheimer's disease	0.000291	0.00234	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—CHRNA7—Alzheimer's disease	0.000289	0.00232	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—GRIK1—Alzheimer's disease	0.000289	0.00232	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.000281	0.00226	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Alzheimer's disease	0.000281	0.00226	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.000278	0.00224	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—Alzheimer's disease	0.000276	0.00222	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—GRIK2—Alzheimer's disease	0.000275	0.00222	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—CHAT—Alzheimer's disease	0.000275	0.00222	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—CHRNA7—Alzheimer's disease	0.000271	0.00218	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—GRIK1—Alzheimer's disease	0.000271	0.00218	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	0.000268	0.00216	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Alzheimer's disease	0.000264	0.00212	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.000262	0.00211	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Alzheimer's disease	0.000258	0.00208	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—Alzheimer's disease	0.000255	0.00205	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.000255	0.00205	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.000255	0.00205	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—CHRNB2—Alzheimer's disease	0.000254	0.00204	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Alzheimer's disease	0.00025	0.00201	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—GRIK1—Alzheimer's disease	0.000248	0.002	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—CHRNA7—Alzheimer's disease	0.000248	0.002	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—CHAT—Alzheimer's disease	0.000246	0.00198	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—GRIK2—Alzheimer's disease	0.000246	0.00198	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	0.000245	0.00197	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Alzheimer's disease	0.000241	0.00194	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Alzheimer's disease	0.000236	0.0019	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—Alzheimer's disease	0.000233	0.00188	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	0.000233	0.00188	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—CHRNB2—Alzheimer's disease	0.000232	0.00187	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	0.000231	0.00186	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—CHAT—Alzheimer's disease	0.000231	0.00186	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—GRIK2—Alzheimer's disease	0.000231	0.00186	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—CHRNA7—Alzheimer's disease	0.000221	0.00178	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—GRIK1—Alzheimer's disease	0.000221	0.00178	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	0.000219	0.00176	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Alzheimer's disease	0.000215	0.00173	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	0.000213	0.00172	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	0.000211	0.0017	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—CHAT—Alzheimer's disease	0.000211	0.0017	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—GRIK2—Alzheimer's disease	0.000211	0.0017	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Alzheimer's disease	0.000211	0.00169	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—Alzheimer's disease	0.000208	0.00168	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—CHRNB2—Alzheimer's disease	0.000207	0.00167	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—GRIA1—Alzheimer's disease	0.000206	0.00165	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	0.000203	0.00164	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	0.000198	0.0016	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.000196	0.00157	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—CHRNB2—Alzheimer's disease	0.000195	0.00157	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	0.000194	0.00156	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	0.000192	0.00154	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	0.00019	0.00153	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.00019	0.00153	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—Alzheimer's disease	0.000189	0.00152	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	0.000188	0.00151	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—GRIK2—Alzheimer's disease	0.000188	0.00151	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—CHAT—Alzheimer's disease	0.000188	0.00151	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—GRIA1—Alzheimer's disease	0.000188	0.00151	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	0.000186	0.0015	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.000182	0.00147	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	0.000182	0.00146	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—ACHE—Alzheimer's disease	0.000179	0.00144	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—CHRNB2—Alzheimer's disease	0.000178	0.00143	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	0.000177	0.00143	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—CHRNA4—Alzheimer's disease	0.000177	0.00142	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.000176	0.00142	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	0.000175	0.00141	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—Alzheimer's disease	0.000173	0.00139	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.000169	0.00136	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—GRIA1—Alzheimer's disease	0.000168	0.00135	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	0.000166	0.00133	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—ACHE—Alzheimer's disease	0.000164	0.00132	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—Alzheimer's disease	0.000163	0.00131	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	0.000162	0.0013	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—CHRNA4—Alzheimer's disease	0.000162	0.0013	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.000161	0.00129	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—CHRNB2—Alzheimer's disease	0.000159	0.00128	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	0.000158	0.00127	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	0.000157	0.00126	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—BCHE—Alzheimer's disease	0.000156	0.00125	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—Alzheimer's disease	0.000154	0.00124	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—DLG4—Alzheimer's disease	0.000152	0.00122	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—Alzheimer's disease	0.000149	0.0012	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—GRIN2B—Alzheimer's disease	0.000149	0.0012	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—PLCB1—Alzheimer's disease	0.000147	0.00118	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—ACHE—Alzheimer's disease	0.000146	0.00117	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—CHRNA4—Alzheimer's disease	0.000144	0.00116	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—BCHE—Alzheimer's disease	0.000142	0.00115	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	0.000142	0.00114	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	0.00014	0.00112	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—DLG4—Alzheimer's disease	0.000139	0.00112	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—GRIN2B—Alzheimer's disease	0.000136	0.00109	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—PLCB1—Alzheimer's disease	0.000134	0.00108	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—Alzheimer's disease	0.000133	0.00107	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	0.00013	0.00104	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.000128	0.00103	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	0.000128	0.00103	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—BCHE—Alzheimer's disease	0.000127	0.00102	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—DLG4—Alzheimer's disease	0.000124	0.000998	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	0.000123	0.000988	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—GRIN2B—Alzheimer's disease	0.000121	0.000976	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—PLCB1—Alzheimer's disease	0.00012	0.000965	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	0.000116	0.000932	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	0.000114	0.000918	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	0.000112	0.000903	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—PRKCG—Alzheimer's disease	0.000109	0.000875	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	0.000105	0.000845	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	0.0001	0.000806	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—PRKCG—Alzheimer's disease	9.94e-05	0.0008	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	9.61e-05	0.000773	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	9.51e-05	0.000765	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	9.49e-05	0.000764	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—CALM1—Alzheimer's disease	9.41e-05	0.000757	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—PRKCG—Alzheimer's disease	8.87e-05	0.000714	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—CALM1—Alzheimer's disease	8.6e-05	0.000692	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	8.58e-05	0.00069	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	8.05e-05	0.000648	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—CREB1—Alzheimer's disease	8.05e-05	0.000648	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—CALM1—Alzheimer's disease	7.68e-05	0.000617	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—CREB1—Alzheimer's disease	7.36e-05	0.000592	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	6.9e-05	0.000555	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—CREB1—Alzheimer's disease	6.57e-05	0.000529	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	5.57e-05	0.000448	CbGpPWpGaD
